title: The hypercoagulability of polycythemia vera.
abstract: Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
authors.affiliation: Brown University.
authors.forename: W
authors.initials: W
authors.lastname: Fields
authors.forename: N J
authors.initials: NJ
authors.lastname: Freeman
mesh_terms: D000368:Aged; D001778:Blood Coagulation Disorders / Q000097:blood* / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D001815:Bloodletting; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011087:Polycythemia Vera / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D013927:Thrombosis / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000628:therapy